Quinolone-3-Diarylethers: A New Class of Antimalarial Drug
Nilsen A., LaCrue AN., White KL., Forquer IP., Cross RM., Marfurt J., Mather MW., Delves MJ., Shackleford DM., Saenz FE., Morrisey JM., Steuten J., Mutka T., Li Y., Wirjanata G., Ryan E., Duffy S., Kelly JX., Sebayang BF., Zeeman A-M., Noviyanti R., Sinden RE., Kocken CHM., Price RN., Avery VM., Angulo-Barturen I., Jiménez-Díaz MB., Ferrer S., Herreros E., Sanz LM., Gamo F-J., Bathurst I., Burrows JN., Siegl P., Guy RK., Winter RW., Vaidya AB., Charman SA., Kyle DE., Manetsch R., Riscoe MK.
ELQ-300, an investigational drug for treating and preventing malaria, shows potent transmission-blocking activity in rodent models of malaria.